Tag Archives: TGTX

TG Therapeutics, Inc. (TGTX)

TG Therapeutics, Inc. (TG) is a biopharmaceutical company focused on the acquisition, development and commercialization of treatments for b-cell malignancies and autoimmune diseases. The Company is developing over two therapies targeting hematological malignancies. TG-1101 (ublituximab) is a glycoengineered monoclonal antibody that targets a specific epitope on the CD20 antigen found on mature....More>>>

News about TGTX

Benzinga's Option Alert Recap From October 12
From:www.benzinga.com
Related GM Auto Stock Roundup: September China Sales Up, Autonomous & EV Move On, Tesla In Focus GM Confirms Production Cutback, Temporary Shutdown In Detroit Plant Why the Market Is Rewarding Gene...Read More>>>

Watch These 8 Huge Call Purchases In Friday Trade
From:www.benzinga.com
...Read More>>>

U.S. stocks set to start week lower in shadow of U.K. terror attacks
From:www.marketwatch.com
U.S. stock futures slipped Monday, as investors tried to look past a fresh terror attack in the U.K. to potentially market-moving events later in the week, and as oil prices rose on a rift among Gulf states. This week will deliver testimony by Federa...Read More>>>

25 Stocks Moving In Monday's Pre-Market Session
From:www.benzinga.com
Gainers Loxo Oncology Inc (NASDAQ: LOXO) rose 32.7 percent to $65.00 in pre-market trading after the company reported that larotrectinib trial demonstrated 76 percent confirmed objective response rate. Dynavax Technologies Corporation (NASDAQ:...Read More>>>

A Profitable And Growing Microcap Investment Bank Focused On The Biotech Sector
From:seekingalpha.com
I first wrote about National Holdings Corp. (NASDAQ:NHLD) in this 3/10/2017 article. NHLD had just reported blowout fiscal Q1 earnings and I predicted "higher growth and profitability" for 2017. NHLD certainly delivered in fiscal Q2. They posted very...Read More>>>